Ocean Biomedical, Inc.

Ocean Biomedical, Inc. (Nasdaq: OCEA) is a biopharmaceutical company that pursued a public listing through a merger with Aesther Healthcare Acquisition Corp., a blank-check company sponsored by Aesther Healthcare Sponsor LLC that completed its IPO in 2021. The company, headquartered in Providence, Rhode Island, focuses on developing therapeutics across oncology, infectious disease, and fibrosis, drawing on a pipeline originated from research at Brown University. Ocean Biomedical filed a Form 10-Q with the SEC on July 11, 2022, under accession number 0001493152-22-019014, reflecting its reporting obligations tied to the de-SPAC process. The company operates in the life sciences and biotechnology sector. For comprehensive filing history, deal terms, sponsor details, and real-time SPAC analytics on OCEA and hundreds of other transactions, sign up for full data access at SpacDesk.